Legis Daily

Expanding Oversight of Opioid Prescribing and Payment Act of 2018

USA115th CongressHR-5723| House 
| Updated: 6/20/2018
Claudia Tenney

Claudia Tenney

Republican Representative

New York

Cosponsors (4)
Suzan K. DelBene (Democratic)Mark Sanford (Republican)James B. Renacci (Republican)David B. McKinley (Republican)

Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Expanding Oversight of Opioid Prescribing and Payment Act of 2018 (Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 9, 2018
Introduced in House
May 9, 2018
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 16, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 16, 2018
Committee Consideration and Mark-up Session Held.
May 22, 2018
Referred to the Subcommittee on Health.
Jun 19, 2018
Placed on the Union Calendar, Calendar No. 592.
Jun 19, 2018
Committee on Energy and Commerce discharged.
Jun 19, 2018
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.
Jun 19, 2018
Mr. Roskam moved to suspend the rules and pass the bill, as amended.
Jun 19, 2018
Considered under suspension of the rules. (consideration: CR H5264-5265)
Jun 19, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.
Jun 19, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)
Jun 19, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)
Jun 19, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 20, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
  • May 9, 2018
    Introduced in House


  • May 9, 2018
    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 16, 2018
    Ordered to be Reported (Amended) by Voice Vote.


  • May 16, 2018
    Committee Consideration and Mark-up Session Held.


  • May 22, 2018
    Referred to the Subcommittee on Health.


  • June 19, 2018
    Placed on the Union Calendar, Calendar No. 592.


  • June 19, 2018
    Committee on Energy and Commerce discharged.


  • June 19, 2018
    Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.


  • June 19, 2018
    Mr. Roskam moved to suspend the rules and pass the bill, as amended.


  • June 19, 2018
    Considered under suspension of the rules. (consideration: CR H5264-5265)


  • June 19, 2018
    DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.


  • June 19, 2018
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)


  • June 19, 2018
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)


  • June 19, 2018
    Motion to reconsider laid on the table Agreed to without objection.


  • June 20, 2018
    Received in the Senate and Read twice and referred to the Committee on Finance.

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
Congressional oversightDrug, alcohol, tobacco useDrug trafficking and controlled substancesHealth information and medical recordsHome and outpatient careHospital careMedicarePrescription drugs

Expanding Oversight of Opioid Prescribing and Payment Act of 2018

USA115th CongressHR-5723| House 
| Updated: 6/20/2018
Expanding Oversight of Opioid Prescribing and Payment Act of 2018 (Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 9, 2018
Introduced in House
May 9, 2018
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 16, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 16, 2018
Committee Consideration and Mark-up Session Held.
May 22, 2018
Referred to the Subcommittee on Health.
Jun 19, 2018
Placed on the Union Calendar, Calendar No. 592.
Jun 19, 2018
Committee on Energy and Commerce discharged.
Jun 19, 2018
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.
Jun 19, 2018
Mr. Roskam moved to suspend the rules and pass the bill, as amended.
Jun 19, 2018
Considered under suspension of the rules. (consideration: CR H5264-5265)
Jun 19, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.
Jun 19, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)
Jun 19, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)
Jun 19, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 20, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
  • May 9, 2018
    Introduced in House


  • May 9, 2018
    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 16, 2018
    Ordered to be Reported (Amended) by Voice Vote.


  • May 16, 2018
    Committee Consideration and Mark-up Session Held.


  • May 22, 2018
    Referred to the Subcommittee on Health.


  • June 19, 2018
    Placed on the Union Calendar, Calendar No. 592.


  • June 19, 2018
    Committee on Energy and Commerce discharged.


  • June 19, 2018
    Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.


  • June 19, 2018
    Mr. Roskam moved to suspend the rules and pass the bill, as amended.


  • June 19, 2018
    Considered under suspension of the rules. (consideration: CR H5264-5265)


  • June 19, 2018
    DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.


  • June 19, 2018
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)


  • June 19, 2018
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)


  • June 19, 2018
    Motion to reconsider laid on the table Agreed to without objection.


  • June 20, 2018
    Received in the Senate and Read twice and referred to the Committee on Finance.
Claudia Tenney

Claudia Tenney

Republican Representative

New York

Cosponsors (4)
Suzan K. DelBene (Democratic)Mark Sanford (Republican)James B. Renacci (Republican)David B. McKinley (Republican)

Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightDrug, alcohol, tobacco useDrug trafficking and controlled substancesHealth information and medical recordsHome and outpatient careHospital careMedicarePrescription drugs